$DORM
Dorman Products, Inc.

2022 Q1 Form 10-Q Financial Statement

#000156459022015422 Filed on April 25, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $401.6M $288.0M
YoY Change 39.43% 11.75%
Cost Of Revenue $268.3M $183.5M
YoY Change 46.23% 6.13%
Gross Profit $133.2M $104.5M
YoY Change 27.5% 23.23%
Gross Profit Margin 33.18% 36.28%
Selling, General & Admin $86.53M $62.90M
YoY Change 37.56% 5.36%
% of Gross Profit 64.94% 60.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.743M $7.300M
YoY Change 33.47% -2.67%
% of Gross Profit 7.31% 6.99%
Operating Expenses $86.53M $62.90M
YoY Change 37.56% 5.18%
Operating Profit $46.71M $41.60M
YoY Change 12.29% 65.99%
Interest Expense $1.231M $121.0K
YoY Change 917.36%
% of Operating Profit 2.64% 0.29%
Other Income/Expense, Net $84.00K $85.00K
YoY Change -1.18% -96.77%
Pretax Income $45.57M $41.62M
YoY Change 9.49% 50.27%
Income Tax $10.36M $8.885M
% Of Pretax Income 22.73% 21.35%
Net Earnings $35.21M $32.73M
YoY Change 7.57% 43.71%
Net Earnings / Revenue 8.77% 11.36%
Basic Earnings Per Share $1.12 $1.02
Diluted Earnings Per Share $1.11 $1.02
COMMON SHARES
Basic Shares Outstanding 31.50M 32.05M
Diluted Shares Outstanding 31.60M 32.18M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $53.43M $166.6M
YoY Change -67.93% 2.97%
Cash & Equivalents $53.43M $166.6M
Short-Term Investments
Other Short-Term Assets $13.51M $9.800M
YoY Change 37.83% -9.26%
Inventory $565.2M $337.7M
Prepaid Expenses
Receivables $456.1M $452.5M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.088B $966.6M
YoY Change 12.58% 13.15%
LONG-TERM ASSETS
Property, Plant & Equipment $116.2M $130.3M
YoY Change -10.8% 31.51%
Goodwill $198.1M
YoY Change
Intangibles $176.1M
YoY Change
Long-Term Investments
YoY Change
Other Assets $47.53M $51.90M
YoY Change -8.43% 17.15%
Total Long-Term Assets $636.1M $297.7M
YoY Change 113.67% -0.28%
TOTAL ASSETS
Total Short-Term Assets $1.088B $966.6M
Total Long-Term Assets $636.1M $297.7M
Total Assets $1.724B $1.264B
YoY Change 36.38% 9.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $165.8M $118.5M
YoY Change 39.95% 61.7%
Accrued Expenses $257.4M $216.9M
YoY Change 18.68% 52.42%
Deferred Revenue
YoY Change
Short-Term Debt $229.4M $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $652.6M $335.4M
YoY Change 94.57% 6.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $94.33M $41.30M
YoY Change 128.4% 210.57%
Total Long-Term Liabilities $94.33M $41.30M
YoY Change 128.4% 210.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $652.6M $335.4M
Total Long-Term Liabilities $94.33M $41.30M
Total Liabilities $764.9M $380.5M
YoY Change 101.03% 16.06%
SHAREHOLDERS EQUITY
Retained Earnings $815.9M
YoY Change 10.62%
Common Stock $67.92M
YoY Change 26.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $959.4M $883.8M
YoY Change
Total Liabilities & Shareholders Equity $1.724B $1.264B
YoY Change 36.39% 9.67%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $35.21M $32.73M
YoY Change 7.57% 43.71%
Depreciation, Depletion And Amortization $9.743M $7.300M
YoY Change 33.47% -2.67%
Cash From Operating Activities $23.21M $21.02M
YoY Change 10.44% 13.07%
INVESTING ACTIVITIES
Capital Expenditures $7.247M $6.207M
YoY Change 16.76% 77.09%
Acquisitions -$595.0K
YoY Change
Other Investing Activities $595.0K $0.00
YoY Change -100.0%
Cash From Investing Activities -$6.652M -$6.207M
YoY Change 7.17% -65.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities -21.96M -3.786M
YoY Change 480.11% -104.08%
NET CHANGE
Cash From Operating Activities 23.21M 21.02M
Cash From Investing Activities -6.652M -6.207M
Cash From Financing Activities -21.96M -3.786M
Net Change In Cash -5.355M 11.03M
YoY Change -148.56% -88.2%
FREE CASH FLOW
Cash From Operating Activities $23.21M $21.02M
Capital Expenditures $7.247M $6.207M
Free Cash Flow $15.97M $14.81M
YoY Change 7.79% -1.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dorm Maximum Credit Terms Allow To Customers
MaximumCreditTermsAllowToCustomers
P365D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y4M24D
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32048000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31601000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32184000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53427000
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Interest Expense
InterestExpense
1231000
CY2021Q1 us-gaap Interest Expense
InterestExpense
121000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
84000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
85000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
45565000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
41615000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10358000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8885000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
35207000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
32730000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1696000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
36903000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32730000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.12
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.11
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31499000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
77451000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58782000
CY2022Q1 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
1357000
CY2021Q4 dorm Allowance For Doubtful Accounts And Customer Credits
AllowanceForDoubtfulAccountsAndCustomerCredits
1326000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
456070000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
472764000
CY2022Q1 us-gaap Inventory Net
InventoryNet
565200000
CY2021Q4 us-gaap Inventory Net
InventoryNet
531988000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13507000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13048000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
1088204000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1076582000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
116225000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
114864000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
98149000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
59029000
CY2022Q1 us-gaap Goodwill
Goodwill
198110000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
176088000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
47525000
CY2022Q1 us-gaap Assets
Assets
1724301000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
165840000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16616000
CY2022Q1 dorm Accrued Customer Rebates And Returns
AccruedCustomerRebatesAndReturns
195289000
CY2021Q4 dorm Accrued Customer Rebates And Returns
AccruedCustomerRebatesAndReturns
188080000
CY2022Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
229360000
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
239360000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
45513000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
33583000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
88881000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
52443000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4916000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
17976000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31479916
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31479916
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31607509
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31607509
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
316000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
856409000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
256000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1440000
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
10000000
CY2022Q1 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-1211000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
959400000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
932736000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1724301000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1673119000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2152000
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
10917000
CY2022Q1 dorm Stock Issued During Period Value Restricted Stock Award Cancelled Net Of Issuances
StockIssuedDuringPeriodValueRestrictedStockAwardCancelledNetOfIssuances
-377000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-1851000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1696000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
35207000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
959400000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
853559000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-931000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
32730000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
883811000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
35207000
CY2022Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
9743000
CY2021Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
7267000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
29000
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
18000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2152000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2111000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8338000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1976000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-12392000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
737000
CY2022Q1 dorm Increase Decrease In Accrued Customer Rebates And Returns
IncreaseDecreaseInAccruedCustomerRebatesAndReturns
7202000
CY2021Q1 dorm Increase Decrease In Accrued Customer Rebates And Returns
IncreaseDecreaseInAccruedCustomerRebatesAndReturns
8215000
CY2022Q1 dorm Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
409000
CY2021Q1 dorm Increase Decrease In Accrued Compensation And Other Liabilities
IncreaseDecreaseInAccruedCompensationAndOtherLiabilities
3869000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23214000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21020000
CY2022Q1 dorm Proceeds From Purchase Price Adjustment
ProceedsFromPurchasePriceAdjustment
595000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7247000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6207000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6652000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6207000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
78574
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
97.16
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10725
CY2021Q1 dorm Proceeds Payments From Other Stock Related Activity
ProceedsPaymentsFromOtherStockRelatedActivity
-932000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
289000
CY2022Q1 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
10752000
CY2021Q1 dorm Purchase And Cancellation Of Common Stock
PurchaseAndCancellationOfCommonStock
3143000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21963000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3786000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5355000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11027000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58782000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
155576000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53427000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
166603000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
999000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
77000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
712000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
167000
CY2022Q1 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
275200000
CY2021Q1 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
209900000
CY2022Q1 dorm Maximum Credit Terms Allow To Customers
MaximumCreditTermsAllowToCustomers
P365D
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
71.89
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
301245
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
83.10
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3319720000
CY2022Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
16918000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
12746000
CY2022Q1 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
203158000
CY2021Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
225879000
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
338014000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
287415000
CY2022Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
7110000
CY2021Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
5948000
CY2022Q1 us-gaap Inventory Net
InventoryNet
565200000
CY2021Q4 us-gaap Inventory Net
InventoryNet
531988000
CY2021Q4 us-gaap Goodwill
Goodwill
197332000
CY2022Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
778000
CY2022Q1 us-gaap Goodwill
Goodwill
198110000
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
194807000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18719000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
176088000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
194807000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15998000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
178809000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3000000.0
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
108.63
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
3600000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
401579000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
288012000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
401579000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
288012000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
206677
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
85.97
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
87378
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
100.70
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
42107
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
89.20
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
23833
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
228115
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
93.09
CY2022Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
400000
CY2021Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
300000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
233396
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
77.85
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
111232
CY2022Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
75.09
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2116745000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27000
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
35207000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
32730000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31499000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32048000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
102000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
136000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31601000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32184000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.12
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.11
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1200000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
2300000
CY2022Q1 dorm Lease Effective Date
LeaseEffectiveDate
2018-01-01

Files In Submission

Name View Source Status
0001564590-22-015422-index-headers.html Edgar Link pending
0001564590-22-015422-index.html Edgar Link pending
0001564590-22-015422.txt Edgar Link pending
0001564590-22-015422-xbrl.zip Edgar Link pending
dorm-10q_20220326.htm Edgar Link pending
dorm-10q_20220326_htm.xml Edgar Link completed
dorm-20220326.xsd Edgar Link pending
dorm-20220326_cal.xml Edgar Link unprocessable
dorm-20220326_def.xml Edgar Link unprocessable
dorm-20220326_lab.xml Edgar Link unprocessable
dorm-20220326_pre.xml Edgar Link unprocessable
dorm-ex311_6.htm Edgar Link pending
dorm-ex312_7.htm Edgar Link pending
dorm-ex32_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
guznr35r5dho000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending